论文部分内容阅读
心肌缺血预处理（ＰＣ）被认为是比当今任何药物都强有力的心肌保护措施。本文主要综述与临床应用有关的实验研究进展及临床缺血预处理研究进展。
Myocardial ischemic preconditioning (PC) is considered a powerful cardioprotective measure of any drug today. This review summarizes the progress of experimental research related to clinical application and the progress of clinical ischemic preconditioning.